STAT1 and nasopharyngeal carcinoma: Together, these results indicated a negative correlation between CBX1 expression and the anti‐PD‐1 response and suggested that targeting CBX1 could inhibit IFN‐γ‐STAT1 signaling‐induced PD‐L1 expression, which might further suppress immune evasion in NPC.